Latest filing published 13 Sept 2019 for Bio-Rad Laboratories, INC..
Filing timeline
BuySaleInsider track record
John Hertia: trading record in brief
John Hertia appears in our data through filings on Bio-Rad Laboratories, Inc. shares, published by SEC (Form 4). We count 70 filings; the first trade dates from 11 September 2014 and the latest from 12 September 2019.
No open-market purchase appears, only 17 sales worth €3.2M. Other entries cover 18 share grants and 35 option exercises. 2019 to date brings no purchases and 9 sales.
Most recently, on 13 September 2019, the filings show a share grant worth €88k in Bio-Rad Laboratories, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Hertia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600 shares0Bio-Rad A Common StockSEC:0001315406-19-000014:0
- 298 shares@ US$326.422.2% of flowBio-Rad A Common StockSEC:0001315406-19-000014:1
- 600 shares@ US$119.541.6% of flowBio-Rad A Common StockSEC:0001315406-19-000016:0
- 600 shares@ US$139.561.9% of flowBio-Rad A Common StockSEC:0001315406-19-000016:1
- 797 shares@ US$328.256.0% of flowBio-Rad A Common StockSEC:0001315406-19-000016:2
- 41 shares@ US$329.000.3% of flowBio-Rad A Common StockSEC:0001315406-19-000016:3
- 600 shares0Bio-Rad A Common StockSEC:0001652252-19-000063:0
- 298 shares@ US$322.932.2% of flowBio-Rad A Common StockSEC:0001652252-19-000063:1
- 600 shares@ US$159.322.2% of flowBio-Rad A Common StockSEC:0001652252-19-000059:0
- 444 shares@ US$336.473.4% of flowBio-Rad A Common StockSEC:0001652252-19-000059:1
- 600 shares0Bio-Rad A Common StockSEC:0001652252-19-000051:0
- 600 shares0Bio-Rad A Common StockSEC:0001652252-19-000051:13
- 208 shares@ US$339.481.6% of flowBio-Rad A Common StockSEC:0001652252-19-000051:1
- 2,400 shares@ US$119.546.6% of flowBio-Rad A Common StockSEC:0001652252-19-000051:2
- 1,800 shares@ US$139.565.7% of flowBio-Rad A Common StockSEC:0001652252-19-000051:3
- 1,200 shares@ US$159.324.4% of flowBio-Rad A Common StockSEC:0001652252-19-000051:4
- 1,200 shares@ US$215.985.9% of flowBio-Rad A Common StockSEC:0001652252-19-000051:5
- 600 shares@ US$326.154.5% of flowBio-Rad A Common StockSEC:0001652252-19-000051:6
- 700 shares@ US$334.775.4% of flowBio-Rad A Common StockSEC:0001652252-19-000051:7
- 1,871 shares@ US$335.6414.3% of flowBio-Rad A Common StockSEC:0001652252-19-000051:8
- 1,231 shares@ US$336.809.5% of flowBio-Rad A Common StockSEC:0001652252-19-000051:9
- 750 shares@ US$338.015.8% of flowBio-Rad A Common StockSEC:0001652252-19-000051:10
- 543 shares@ US$338.974.2% of flowBio-Rad A Common StockSEC:0001652252-19-000051:11
- 100 shares@ US$340.000.8% of flowBio-Rad A Common StockSEC:0001652252-19-000051:12
- 298 shares@ US$335.592.3% of flowBio-Rad A Common StockSEC:0001652252-19-000051:14
25 of 70 declarations
